
Välj din etikett
visas direkt på vialenLabbrapport
PDF- Testad
- Dutasteride 1mg × 100 Tabs
- Labb
- Analiza Białek
- Datum
- October 2026
- Resultat
- 1.02 mg per tablet (1 mg label)
- Beställningsnr.
- Lösenord
Oberoende testad, kan verifieras med lösenordet direkt hos labbet.
Dutasteride
Hair & Skin
- Labbtestad
- Skickas från Tyskland
Beställning
- DHL med spårning
- Diskret förpackning
4.6 av 5 på Trustpilot73 omdömen
Söks även som: Dutasterid
I korthet
Dutasteride i siffror
Nyckeltalen från vårt lexikon. Dra punkten längs kurvan för att se hur mycket som finns kvar efter en dos, beräknat.
Hela lexikonartikelnHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~5 weeks
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
about5weeks
- Class
- 5α-reductase inhibitor type 1 and type 2
- Use
- Oral1 tablet per day or every other day
- Sizes
- 1 mg1 size in the shop
What studies show
All 2 sources in the lexiconDutasteride vs finasteride in androgenetic alopecia (opens in a new tab)
Olsen et al., J Am Acad Dermatol, 2006
Kunskap
Allt om Dutasteride
Detaljerad information kommer snart.
Is dutasteride approved?
Yes. In the USA it has been approved as a prescription drug for the enlarged prostate since 20 November 2001, ChEMBL lists phase 4 as the highest phase. In hereditary hair loss it is used outside this approval, there are phase 3 trials on this.
How does dutasteride differ from finasteride?
Finasteride blocks only 5-alpha reductase type 2, dutasteride both types. In a comparison trial in men with enlarged prostate blood DHT fell by 94.7 percent with the approved dose of dutasteride and by 70.8 percent with finasteride. With finasteride the values also varied much more.
What do the hair loss trials show?
The first trial with 416 men already showed more hair in a dose-dependent way, the highest dose beat finasteride. In a trial with 917 men the approved dose grew more and thicker hairs after 24 weeks than finasteride and placebo. In a Korean phase 3 trial hair count rose by 12.2 per square centimetre in 6 months, on placebo by 4.7. All trials lasted at most 6 months.
What does research show for the prostate?
In three identical trials with 4,325 men the prostate shrank by 25.7 percent in 24 months, symptoms fell by 21.4 percent and urine flow rose. The risk of acute urinary retention fell by 57 percent, of surgery by 48 percent. In the CombAT trial the combination with tamsulosin worked better on symptoms over 4 years than either drug alone.
Does dutasteride lower prostate cancer risk?
In the 4-year REDUCE trial prostate cancer was found less often on dutasteride, 22.8 percent less in relative terms. Aggressive tumours with Gleason 8 to 10, however, were more common in years 3 and 4, 12 against 1. The composite term heart failure was also more common at 0.7 against 0.4 percent.
Which side effects have been described?
In the prostate trials impotence, reduced libido, breast enlargement and ejaculation disorders occurred more often than on placebo, but rarely overall. Except for breast enlargement they became less frequent over time. A meta-analysis in hair loss found a 1.37-fold risk of sexual side effects for dutasteride, not statistically significant. In direct comparison with finasteride there was no clear difference.
Jämförelser
Hur den står sig
Relaterat
Relaterade produkter
Snap-8
Peptider · Kognition & sömn Kognition & sömn
1 storlek
= 11.6 €/vial
PTD-DBM
Peptider · Anti-aging Anti-aging
1 storlek
= 56.8 €/vial
Healthy Hair Skin Nails Blend
Peptider · Specialprodukter & stöd Specialprodukter & stöd
1 storlek
per burk
Finasteride
Läkemedel · Hormoner och urologi Hormoner och urologi
3 storlekar
Dutasteride
